Global Infectious Diseases Diagnostics Market 2023: STDs to Remain Largest Segment; APAC Continues Dominance, Followed by MEA

The infectious diseases diagnostics market is a sector of the healthcare industry that focuses on the development and production of diagnostic tests for infectious diseases. These tests are used to identify the presence of infectious agents in patients and can help healthcare professionals determine the best course of treatment. In 2022, the infectious diseases diagnostics market is expected to continue growing as new technologies and diagnostic methods are developed and more people around the world gain access to healthcare services.

Request For Free Sample Report of "Infectious Diseases Diagnostics Market"@ https://www.persistencemarketresearch.com/samples/11413

According to the latest market report published by Persistence Market Research, titled "Global Market Study on Infectious Diseases Diagnostics: Increasing Demand for Evidence-Based Treatment to Boost Demand for Infectious Diagnostic Testing during Forecast Period". The global market for infectious diseases diagnostics is estimated to reach US$ 876.6 Mn in 2016 from US$ 827.7 Mn in 2015 owing to increasing demand for diagnostic kits caused by rising incidence rate of infectious diseases.

The global infectious disease diagnostics market is expected to reach US$ 1503.8 Mn by 2024. Sexually Transmitted Diseases (STDs) segment is expected to continue to remain the largest segment by diseases indication accounting for US$ 282.4 Mn in terms of revenue in 2016, a Y - o - Y increase of 7.0% over 2015. The chlamydia diagnostics test kits are expected to gain upward momentum in 2016, growing at 8.9% in terms of revenue, the fastest among disease indication segment.

Companies

Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratories
bioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Alera Inc.
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.
Other
Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/11413

Cell cultures segment is expected to register highest CAGR in terms of revenue, by test type accounting for US$ 311.4 Mn in terms of revenue in 2016. The affordability of cell culture kits and large applications in diagnosis of several infectious diseases is gaining traction. Consumption demand for cell culture test kits will witness a growth rate of 7.2 % in 2016 over 2015.

Diagnostic centers end user segment is expected to register highest CAGR in terms of revenue, accounting for US$ 392.8 Mn in terms of revenue in 2016. The increasing number of diagnostics centers, worldwide and a large number of patient pool depending on diagnostics centers for diagnosis of infectious diseases is expected to increase demand for diagnostics tests among diagnostics centers. The diagnostics centers end user segment will witness a growth rate of 7.4 % in 2016 over 2015.

Becton, Dickinson and Company, Cepheid, Inc. Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc. are key players in the market. Top players are focusing on developing new products and improving sensitivity and specificity of the test kits. Collaborations and joint ventures among manufacturers and local governments are key business strategies being adopted to increase market share.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/11413

Key Questions Answered in This Report.

What are the Roadblocks for Infectious Diseases Diagnostics Market Suppliers?
What are the Key Opportunities for Infectious Diseases Diagnostics Market Manufacturers?
How is Focus on Safety Influencing Infectious Diseases Diagnostics Market Demand?
What is the Regulatory Impact on Global Sales of Infectious Diseases Diagnostics Market?
Which Region Offers the Largest Opportunity for Sales of Infectious Diseases Diagnostics Market?
Where Does the U.S. Stand in the Market for Infectious Diseases Diagnostics Market?
What Is the Outlook for Infectious Diseases Diagnostics Market Manufacturers in China?
Why is Germany a Lucrative Market for Infectious Diseases Diagnostics Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Infectious Diseases Diagnostics Market?
Why is There High Demand for Tires in Infectious Diseases Diagnostics Market?
Why are Sales of Infectious Diseases Diagnostics Market Surging?

For More Premium Insights, Check out the Link:

Autogenous Vaccines Market - https://www.prnewswire.com/news-releases/autogenous-vaccines-market-is-predicted-to-witness-an-impressive-cagr-of-5-5-over-the-forecast-period-2021-2031--persistence-market-research-301264988.html

Hematology Analyzers Market - https://www.prnewswire.com/news-releases/hematology-analyzers-market-will-exhibit-a-5-cagr-during-the-forecast-period-2020-to-2030---persistence-market-research-301187222.html

Bioabsorbable Implants Market - https://www.prnewswire.com/news-releases/bioabsorbable-implants-market-is-expected-to-grow-at-a-healthy-cagr-of-3-4-by-2018-to-2028---persistence-market-research-300850551.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.